top of page
About us
Our technology
Our pipeline
Our people
Investor relations
News & publications
Contact us
GeneToBe is leading the way
in next-generation gene therapy
Our technology
Gene silencing therapeutics and DNA repair CRISPR MiCas9 platform with improved gene editing capabilities to bring new therapies to patients.
Gene therapies to address
debilitating diseases
Driving innovation and addressing diseases in
genetically-defined patient populations.
Our pipeline
Our leadership team
Esprit de corps. Innovation, talent, and the power of diverse perspectives.
This is what defines us and drives us forward.
Our people
Anchor 4
Investor relations
Partnership, collaboration and
investment to drive our mission.
Collaborate
bottom of page